Latest News in the pharma Industry

Biopharma News

Strong Pipeline of Monoclonal Antibodies (mAbs) Biosimilars in the US and Europe Lends Impetus to Global Market

Strong Pipeline of Monoclonal Antibodies (mAbs) Biosimilars in the US and Europe Lends Impetus to Global Market

31 Jan 2014

Read more 
Biogen Idec and UCB Enter Agreements to Commercial?ise Multiple Sclerosis and Hemophilia Therapies in Asia

Biogen Idec and UCB Enter Agreements to Commercial?ise Multiple Sclerosis and Hemophilia Therapies in Asia

30 Jan 2014

Read more 
New Findings Demonstrate Technological Advances for Extending Serum Half-Life of Drugs Bound to Albumin

New Findings Demonstrate Technological Advances for Extending Serum Half-Life of Drugs Bound to Albumin

28 Jan 2014

Read more 
Shire Executes Agreement to Divest DERMAGRAFT

Shire Executes Agreement to Divest DERMAGRAFT

21 Jan 2014

Read more 
Horizon Discovery and Transgenomic Announce Collaboration for Validation Control and Development of Genetic Diagnostic Tests

Horizon Discovery and Transgenomic Announce Collaboration for Validation Control and Development of Genetic Diagnostic Tests

20 Jan 2014

Read more 
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics

Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics

14 Jan 2014

Read more 
Lonza Signs Exclusive Agreement with Index Ventures for the Development and Manufacture of Biologics for Portfolio Companies

Lonza Signs Exclusive Agreement with Index Ventures for the Development and Manufacture of Biologics for Portfolio Companies

9 Jan 2014

Read more 
Scholar Rock to Collaborate with Johnson & Johnson Innovation to Discover and Develop Novel Biologics for the Treatment of Autoimmune Diseases and Cancer

Scholar Rock to Collaborate with Johnson & Johnson Innovation to Discover and Develop Novel Biologics for the Treatment of Autoimmune Diseases and Cancer

9 Jan 2014

Read more 
Rakesh Bamzai Joins Mylan as President, India Commercial and Emerging Markets

Rakesh Bamzai Joins Mylan as President, India Commercial and Emerging Markets

6 Jan 2014

Read more 
Ready-to-Use Stable Cell Lines

Ready-to-Use Stable Cell Lines

2 Jan 2014

Read more 
Jazz Pharma Trades $1B for Gentium and a Well-Travelled Orphan Drug

Jazz Pharma Trades $1B for Gentium and a Well-Travelled Orphan Drug

23 Dec 2013

Read more 
Sandoz Begins Phase III Clinical Trial for Biosimilar Adalimumab

Sandoz Begins Phase III Clinical Trial for Biosimilar Adalimumab

19 Dec 2013

Read more